SCHEMBL525865

SCHEMBL525865

Cc1nc2c(F)cc(S(=O)(=O)Cl)cc2c(=O)[nH]1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 8/20 0.49
KDM4E B2RXH2 4/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
PARG Q86W56 1/20 0.39
NPC1 O15118 2/20 0.38
ALDH1A1 P00352 2/20 0.38
MAPT P10636 2/20 0.38
RAB9A P51151 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
USP2 O75604 1/20 0.38
GLA P06280 1/20 0.38
GAA P10253 1/20 0.38
HPGD P15428 1/20 0.38
PIM1 P11309 1/20 0.37
PIM2 Q9P1W9 1/20 0.37
TNKS2 Q9H2K2 2/20 0.37
TYMS P04818 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19992165 0.78 PARP1 (0.57) PARP1KDM4ECYP1A2CYP2D6CYP2C9
SCHEMBL527607 0.76 CA12 (0.44) PARP1KDM4ECYP1A2CYP2D6CYP2C9
SCHEMBL25112470 0.75 PARP1 (0.54) PARP1KDM4ECYP1A2CYP2D6CYP2C9
SCHEMBL526063 0.75 PARP1 (0.54) PARP1KDM4ECYP1A2CYP2D6CYP2C9
SCHEMBL29991941 0.75 PARG (0.61) PARP1KDM4EPARGNPC1ALDH1A1
SCHEMBL527853 0.75 IP6K1 (0.51) PARP1ALDH1A1PIM1PIM2IP6K1
SCHEMBL29991873 0.72 KDM4E (0.50) PARP1KDM4EPARGNPC1ALDH1A1
SCHEMBL525453 0.72 PARP1 (0.50) PARP1KDM4ECYP1A2CYP2D6CYP2C9
SCHEMBL527342 0.71 PGR (0.34) PARP1KDM4EPARGALDH1A1MAPT
SCHEMBL526074 0.70 PARP1 (0.70) PARP1KDM4ECYP1A2CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012014109-A1 HETEROCYCLIC SULFONAMIDES AS INHIBITORS OF TRANSFER RNA SYNTHETASE FOR USE AS ANTIBACTERIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2012-02-02 WO disclosed